Tamoxifen-Loaded Eudragit Nanoparticles: Quality by Design Approach for Optimization of Nanoparticles as Delivery System
Pharmaceutics · 22.09.2023 · 15 (10) · 2373
DOI: 10.3390/pharmaceutics15102373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 22.09.2023. Verfasst von Muzna Ali Khattak und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Higher Education of Pakistan (HEC), King Saud University, Riyadh, Saudi Arabia.
Abstract (Originalsprache)
Nanoparticles have numerous applications as drug carriers in drug delivery. The aim of the study was to produce tamoxifen nanoparticles with a defined size and higher encapsulation for efficient tissue uptake with controlled drug release. The quality by design approach was utilized to produce tamoxifen-loaded Eudragit nanoparticles by identifying the significant process variables using the nanoprecipitation method. The process variables (amount of drug, polymer, and surfactant) were altered to analyze the influence on particle size (PS), % encapsulation efficiency (EE). The results showed that the drug and polymer individually as well as collectively have an impact on PS, while the surfactant has no impact on the PS. The %EE was influenced by the surfactant individually and in interaction with the drug. The linear regression model was endorsed to fit the data showing high R2 values (PS, 0.9146, %EE, 0.9070) and low p values (PS, 0.0004, EE, 0.0005). The PS and EE were confirmed to be 178 nm and 90%, respectively. The nanoparticles were of spherical shape, as confirmed by SEM and TEM. The FTIR confirmed the absence of any incompatibility among the ingredients. The TGA confirmed that the NPs were thermally stable. The in vitro release predicted that the drug release followed Higuchi model.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.
- Department of Pharmacy, Cecos University of IT and Emerging Sciences, Peshawar 25000, Pakistan.
- Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar 25000, Pakistan.
- Philadelphia College of Pharmacy, University of Sciences, Philadelphia, PA 19104, USA.
- Pharmacy Department, Faculty of Health and Medical Sciences, Mirpur University of Science and Technology, New Mirpur City 10250, Pakistan.
- Department of Pharmacy, University of Swabi, Swabi 23430, Pakistan.
ORCID-Profile: Fazli Nasir, Fawaz Alasmari, Arbab Tahir
Förderung
- Higher Education of Pakistan (HEC)
- King Saud University, Riyadh, Saudi Arabia
Zitieren
APA
Khattak, M. A., Iqbal, Z., Nasir, F., Neau, S. H., Khan, S. I., Hidayatullah, T., Pervez, S., Sakhi, M., Zainab, S. R., Gohar, S., Alasmari, F., Rahman, A., Maryam, G. E., & Tahir, A. (2023). Tamoxifen-Loaded Eudragit Nanoparticles: Quality by Design Approach for Optimization of Nanoparticles as Delivery System. Pharmaceutics, 15(10), 2373. https://doi.org/10.3390/pharmaceutics15102373
Vancouver
Khattak MA, Iqbal Z, Nasir F, Neau SH, Khan SI, Hidayatullah T, et al. Tamoxifen-Loaded Eudragit Nanoparticles: Quality by Design Approach for Optimization of Nanoparticles as Delivery System. Pharmaceutics. 2023;15(10):2373. doi:10.3390/pharmaceutics15102373
BibTeX
@article{Khattak2023,
author = {Khattak, Muzna Ali and Iqbal, Zafar and Nasir, Fazli and Neau, Steven H and Khan, Sumaira Irum and Hidayatullah, Talaya and Pervez, Sadia and Sakhi, Mirina and Zainab, Syeda Rabqa and Gohar, Shazma and Alasmari, Fawaz and Rahman, Altafur and Maryam, Gul E and Tahir, Arbab},
title = {Tamoxifen-Loaded Eudragit Nanoparticles: Quality by Design Approach for Optimization of Nanoparticles as Delivery System},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {10},
pages = {2373},
doi = {10.3390/pharmaceutics15102373}
}
EUVIMED